Evidence map›Paper›PMID 37340572›Full record

ArticleUltrasonography (Seoul, Korea)2023

Modified CEUS LI-RADS using Sonazoid for the diagnosis of hepatocellular carcinoma.

Katsutoshi Sugimoto, Naohisa Kamiyama, Tatsuya Kakegawa, Hiroshi Takahashi, Takuya Wada, Masakazu Abe, Yu Yoshimasu, Hirohito Takeuchi, Takao Itoi

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Ultrasonography (Seoul, Korea), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Katsutoshi SugimotoDepartment of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan.
Naohisa KamiyamaUltrasound Division, GE HealthCare, Hino, Tokyo, Japan.
Tatsuya KakegawaDepartment of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan.
Hiroshi TakahashiDepartment of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan.
Takuya WadaDepartment of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan.
Masakazu AbeDepartment of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan.
Yu YoshimasuDepartment of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan.
Hirohito TakeuchiDepartment of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan.
Takao ItoiDepartment of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan.
Tokyo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review outlines several modified versions of the contrast-enhanced ultrasonography Liver Imaging Reporting and Data System (CEUS LI-RADS) that utilize Sonazoid. Furthermore, it discusses the advantages and challenges of diagnosing hepatocellular carcinoma using these guidelines, as well as the authors' expectations and opinions regarding the next CEUS LI-RADS version. It is possible that Sonazoid could be incorporated into the next version of CEUS LI-RADS.

Indexed as

Contrast-enhanced ultrasoundHepatocellular carcinomaKupffer cell agentsModified CEUS LI-RADSSonazoid

Identifiers

PMID37340572
PMCPMC10331059
OpenAlexW4378767757

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.